Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus late steroid therapy for chemotherapy-induced myocarditis after CRS and HIPEC
PACTR202001797822250Phase 0Not yet recruiting
- Sponsor
- National Cancer Institute
- Start
- Jan 2020
- Countries
- 1
01
Overview
Phase 0, open-label trial of corticosteroids in myocarditis (2 arms), sponsored by National Cancer Institute. Primary endpoint: Primary efficacy endpoint. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
corticosteroids
03
Conditions
myocarditis
Beyond the preview
Go deeper on PACTR202001797822250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001797822250.